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arteriovenous ﬁstulas with aneurysm-related
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Majid Tayarrah, MD, Fontana, Calif
Objective: Aneurysm-related complications could lead to loss of a functioning arteriovenous ﬁstula (AVF). We report our
midterm and long-term results with the staple aneurysmorrhaphy technique to repair and preserve aneurysmal AVFs.
Methods:We retrospectively reviewed our surgical treatment of patients with aneurysmal autogenous AVF complicated by
skin erosion, bleeding, infection, pain, and difﬁculty with needle access from 2007 through 2014. We identiﬁed 52
patients, 40 (77%) of whom underwent repair with the staple aneurysmorrhaphy technique. The operation involved
mobilizing the entire aneurysmal segments. A TA (Covidien, Norwalk, Conn) or Endo GIA (Covidien, Mansﬁeld, Mass)
stapler was used to resect the redundant aneurysm wall to create a 6- to 8-mm-diameter conduit. A subcutaneous skin ﬂap
was created after excising compromised skin. The remodeled vein was repositioned underneath the subcutaneous ﬂap,
with the staple line rotated laterally to avoid needle puncture.
Results: We attempted staple aneurysmorrhaphy in 40 patients with complicated AVF aneurysms, of which 38 repairs
(95%) were successful. Median patient age was 66 years (range, 29-88 years). Median AVF age was 63 months (range, 12-
136 months). Median follow-up was 20 months (range, 5-81 months). At 1 year, primary patency was 67%, assisted
primary patency was 88%, and secondary patency was 91%. At 2 years, primary patency was 59%, assisted primary patency
was 84%, and secondary patency was 91%. At 3 years, primary patency was 46%, assisted primary patency was 69%, and
secondary patency was 85%. Surgery was performed under local-regional anesthesia in 28 patients (70%) and under
general anesthesia in the remaining 12 (30%). Proximal venous outﬂow stenoses were detected in 19 of 40 AVFs (48%)
preoperatively and in 11 of 38 AVFs (29%) postoperatively. Aneurysm recurrence occurred in two repaired AVFs.
Conclusions: Our experience with staple aneurysmorrhaphy shows that it is an effective, safe, and durable procedure to
preserve a functioning autogenous AVF with complicated aneurysmal degeneration. Key principles are to reduce the vein
to normal adjacent diameter and to provide healthy skin coverage. The remodeled AVF has a low aneurysm recurrence
rate and maintains the beneﬁcial properties of superior patency and low infection. It is important to aggressively monitor
for and treat proximal outﬂow venous stenoses to prevent aneurysm recurrence. The surgery can be done safely under
local anesthesia in selected patients. (J Vasc Surg 2015;61:457-62.)Autogenous arteriovenous ﬁstula (AVF) use in the
United States increased from 27.9% in 1998 to 55% in
2007.1 Aneurysm formation is one of the most common
complications of long-term AVF use.2 The risk of AVF
aneurysm formation has been reported from 6% to as high
as 60%.3,4 The National Kidney Foundation Kidney Disease
Outcomes Quality Initiative (NFK-KDOQI) guidelines
recommend revision of an AVF aneurysm if the skin over-
lying the ﬁstula is compromised, there is a risk of ﬁstula
rupture, or available puncture sites are limited.1the Department of Vascular Surgery, Kaiser Permanente.
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://dx.doi.org/10.1016/j.jvs.2014.09.008Several surgical techniques have been used to address
aneurysmal AVFs.5-8 Surgical aneurysmorrhaphy involves
resection of a portion of the aneurysmal wall and primary
closure using the remaining wall, thus preserving an autog-
enous AVF. Several authors have performed surgical aneur-
ysmorrhaphy using a mechanical stapler.9-11 We report our
experience during the past 7 years with staple aneurysmor-
rhaphy to preserve complicated aneurysmal AVFs in a
larger cohort of patients and with longer follow-up than
previously described.
METHODS
A retrospective review of operative cases was performed
at a single health plan hospital, Kaiser Permanente, Fontana
Calif, from 2007 through 2014. Our Institutional Review
Board approved the study, and informed consent was not
required for the data analysis. Data were retrieved from
our electronic medical record system. Patients who pre-
sented with a true AVF aneurysm and related complications
of bleeding, skin erosion, infection, pain, and difﬁculty with
needle cannulation were selected. A true AVF aneurysm was
deﬁned as being twice the diameter of the normal adjacent457
Fig 1. Staple aneurysmorrhaphy technique. A, A longitudinal incision is made over the aneurysmal segments with
complete mobilization of the vein. B, The aneurysm is reduced in size to match adjacent normal vein using a TA stapler
(Covidien, Norwalk, Conn). C, The staple line is oriented laterally under a subcutaneous skin ﬂap to avoid puncture
along the staple line. D, Multilayered closure.
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rysms. Dissection intraoperatively revealed an aneurysm
wall that was continuous with the adjacent normal vein. His-
tologic evaluation was obtained in some cases.
Skin compromise ranged from frank ulceration to
eschar formation and thinning at risk for rupture. Patients
underwent routine screening surveillance ultrasound imag-
ing and physical examinations preoperatively and postoper-
atively at 1 month, 6 months, and yearly thereafter.
Patients underwent venogram with percutaneous balloon
angioplasty if ultrasound imaging revealed >50% stenosis
or if pulsatility was palpated along the entire length of
the AVF. Ultrasound-detected >50% stenosis was based
on a doubling of velocity across the stenosis.
The Kaplan-Meier survival analysis method was used to
determine patency. Assisted primary patency consisted of
AVFs that did not require surgical revisions and were
treated only with percutaneous balloon angioplasty.
Staple aneurysmorrhaphy was done under local-regional
anesthesia (interscalene or supraclavicular nerve block) or
general anesthesia (Fig 1). Most patients required preopera-
tive placement of a tunneled hemodialysis catheter. A longi-
tudinal skin incision was made over the aneurysmal portions
of the AVF and extended onto normal-caliber vein. The
AVF was completely mobilized from the surrounding tissue
after proximal and distal control was obtained with vessel
loops. An ellipse of skin was left intact on the aneurysm
around any ulcerated areas to avoid bleeding.
Intravenous heparin was not routinely given because
the inﬂow occlusion time was only a few minutes. The
inﬂow was clamped while the venous outﬂow was left
open to allow decompression of the aneurysm. The aneu-
rysm wall was grasped and elevated preferably on the lateralaspect if possible. A TA stapler (3.5 mm depth; Covidien,
Norwalk, Conn) or Endo GIA stapler (Covidien, Mans-
ﬁeld, Mass) with a vascular load was applied across the
aneurysm to approximate the normal-caliber adjacent
vein, w6 to 8 mm. The stapler was closed and inﬂow
restored to check the ﬂow and diameter. The stapler was
readjusted as needed to widen or narrow the lumen.
Once satisﬁed with the vein diameter, the stapler was ﬁred
and the redundant wall excised. The staple line was
routinely reinforced with a running 5-0 polypropylene su-
ture, even though hemostasis was good most of the time.
Compromised and redundant skin was excised. A subcu-
taneous skin ﬂap was elevated. The remodeled vein was posi-
tioned and tacked under the ﬂap, with the staple line
orientated laterally to avoid direct needle puncture. The sub-
cutaneous ﬂaps were closed in two layers using absorbable
sutures, followed by a subcuticular or staple skin closure.
Staple aneurysmorrhaphy was used for all AVFs in our
series, but other additional procedures were required in
some cases to treat adjacent aneurysms. Two aneurysms
with intraluminal thrombus were seen on ultrasound imag-
ing. These aneurysms were opened to remove the
thrombus and the wall was trimmed and then primarily
closed with running 5-0 polypropylene suture. When there
were multiple aneurysms with redundant and tortuous vein
length, the redundant aneurysmal portions were resected
and reconstructed with an end-to-end anastomosis. This
created a straighter conduit to facilitate needle access.
RESULTS
A review of our database identiﬁed 52 patients oper-
ated on for AVF aneurysm-related complications. Of the
52 patients, 40 (77%) underwent staple aneurysmorrhaphy
Fig 2. Kaplan-Meier survival analysis shows primary patency, assisted primary patency, and secondary patency of
arteriovenous ﬁstulas (AVFs) that were repaired with staple aneurysmorrhaphy.
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position with polytetraﬂuoroethylene graft. There were
72 aneurysms repaired among the 40 patients who had sta-
ple aneurysmorrhaphy. Only eight patients had a single
aneurysm compared with 32 patients with multiple diffuse
aneurysms occurring mainly at the puncture sites. Mean
aneurysm diameter was 4.5 cm (range, 3-8 cm). The
mean ﬂow volume on ultrasound imaging was 1712 (stan-
dard deviation [SD], 758) mL/min. Flow volume was
measured in the straightest portion of the AVF as possible,
away from the aneurysms and arterial anastomosis. Histo-
logic evaluation was obtained in 10 of the aneurysms and
conﬁrmed an intact wall with endothelial and smooth mus-
cle cells present.
Patients were a median age of 66 years (range, 29-
88 years), and there were 19 women and 21 men. Ethnicity
consisted of 16 Hispanics, 12 Caucasians, 9 African Amer-
icans, and 3 Asians. Indications for surgery were aneurysms
complicated by skin erosion in 35 (87.5%), infection in
three (7.5%), and difﬁculty with needle cannulation in
two (5%). Bleeding occurred in 13 of the 35 patients
(37%) with skin erosion and occurred mostly at the needle
puncture sites. Median AVF age at time of repair was
63 months (range, 12-136 months). The types of AVF
were brachiocephalic in 20 (52%), radiocephalic in 12
(31.5%), brachiobasilic in 7 (18%), and proximal radioba-
silic in 1 (2.6%). Eight basilic veins were formally trans-
posed, and four cephalic veins were superﬁcialized.
Technical success was deﬁned as reconstruction of an
AVF that was usable by 4 weeks. The staple aneurysmor-
rhaphy procedures were successful 38 of the 40 patients
(95%). There were two failures. The ﬁrst failure presented
as a large pseudoaneurysm due to disruption of the staple
line 1 week postoperatively. The second failure was due
to a severely calciﬁed vein that was not amenable to placing
sutures or staples. Aneurysmorrhaphy was abandoned and
an interposition polyurethane graft inserted. A tunneled
hemodialysis catheter was placed preoperatively in 33 of
the 40 patients (83%). The remodeled AVFs were used at4 weeks, and the hemodialysis catheter removed at 5 to
6 weeks after surgery.
Staple aneurysmorrhaphy was performed under local-
regional anesthesia in 28 patients (70%) and under general
anesthesia in 12 (30%). Mean operative time was 130.1
(SD, 49.09) minutes. Operative times were longer with
general anesthesia (mean, 152 minutes) compared with
local anesthesia (mean, 122 minutes), although this did
not reach statistical signiﬁcance (P ¼ .119).
Preoperative evaluation using ultrasound imaging and
physical examination identiﬁed 19 of 40 AVFs (48%) with
venous stenoses that required balloon angioplasty. Distri-
butions of the venous stenoses were 11 cephalic arch junc-
tions, ﬁve subclavian and innominate veins, and ﬁve
intraﬁstula locations. Postoperative surveillance found
venous stenoses requiring balloon angioplasty in 11 of
38 AVFs (29%). All but one of the postoperative venous
stenoses was recurrent in nature. The stenosis identiﬁed
postoperatively that was not recurrent occurred at the
juxta-anastomotic location.
Seven deaths occurred during the follow-up period,
and aneurysms that required ligation recurred in two of
the 38 AVFs (5%). There were no postoperative wound
complications such as infection, hematoma, lymphatic
leak, or skin ﬂap necrosis. There was no 30-day mortality.
Median follow-up was 20 months (range, 5-81 months).
Follow-up was at least 10 months for 75% of patients and
at least 31 months for 25%. At 1 year, primary patency
was 67%, assisted primary patency was 88%, and secondary
patency was 91%. At 2 years, primary patency was 59%,
assisted primary patency was 84%, and secondary patency
was 91%. At 3 years, primary patency was 46%, assisted pri-
mary patency was 69%, and secondary patency was 85%
(Fig 2).
DISCUSSION
Our institution has improved the use of autogenous
AVF to 87% among our health plan members who require
hemodialysis, in accordance with the NFK-DOQI Fistula
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complications due to AVF aneurysms. Skin erosion was the
main presenting problem and was associated with bleeding
about a third of the time. Most of our patients were being
punctured in the aneurysmal segments, despite NFK-
KDOQI guidelines to avoid needle puncture in these
areas.1 This may have been due to lack of awareness by
the dialysis staff or insufﬁcient available puncture sites along
the AVF, or both. We recommend early repair of aneu-
rysmal AVFs in situations where cannulation sites are
limited to prevent skin erosion and bleeding. Aneurysmal
AVFs commonly have redundant and tortuous segments
that can be revised to provide better needle access.
Our series focused on the surgical treatment of compli-
cated true AVF aneurysms. We used several criteria to
distinguish between a true AVF aneurysm vs pseudoaneur-
ysm. Only autogenous AVF aneurysms were included. Ul-
trasound imaging showed an intact and contiguous vein
wall from normal to aneurysmal areas. Intraoperatively,
complete mobilization of the aneurysm demonstrated a
wall that had a uniform and continuous transition to the
normal adjacent vein. Lastly, the histologic assessment
conﬁrmed the presence of intimal, medial, and adventitial
layers.8 Histologic conﬁrmation was available in only 10
cases. We do not believe this was a limitation, because
the gross appearance of a true aneurysm after surgical
dissection was very distinctive. Whether the aneurysm
wall is a true wall with three layers or a pseudoaneurysm
wall composed of ﬁbrous tissue, the critical aspect is
whether the wall is strong enough to be remodeled with
staples and sutures.
Various approaches for dealing with AVF aneurysms
have been described. Ligation and resection, followed by
creation of a new access, have the disadvantages that a he-
modialysis catheter will be required for a prolong length of
time and there may not be suitable veins for another autog-
enous AVF. Another option is ligation with interposition
bypass using a prosthetic graft.5 However, this converts
the access into an arteriovenous graft (AVG) with inferior
patency and higher infection risk.12 Interposition bypass
has been done using great saphenous vein, but this is
limited by the size and quality of the vein.8
Covered stent graft treatment for arteriovenous access
aneurysms has been reported, but there are concerns
regarding higher infectious complications.13,14 We were
reluctant to place stents in areas that would subsequently
be cannulated due to concerns for stent fracture, throm-
bosis, and infection. In addition, bacterial colonization of
aneurysms may occur if there is ulcerated skin and can sub-
sequently result in infection of the stent graft. Our limited
experience of placing stent grafts in three patients with
AVF aneurysms ultimately resulted in loss of the AVFs
due to infection. Endovascular stent graft placement may
have a role for an emergency in a high-risk patient.13
Various techniques have been used to repair AVF aneu-
rysms, with the goal of maintaining an autogenous ﬁstula.
Hakim et al9 described refashioning six aneurysmal AVFs
using an Endo GIA 60 stapler for steal syndrome, bleeding,and pain. Pierce et al10 reported reduction aneurysmoplasty
in 12 patients using a TA stapler. Their indications were
difﬁculty with needle cannulation and pain. Other authors
have used a running suture repair instead of a mechanical
stapler.15
Our series consisted of 40 patients. We cautiously
started using staple aneurysmorrhaphy to repair AVF aneu-
rysms in 2007. We began with the simplest casesdsmall
aneurysms, stable patient, and no skin ulcerations or
bleedingdunder general anesthesia. As our experience
increased, we expanded the technique to include a broader
range of patients. Ten of the 12 patients excluded during
the study period occurred during the early stage, when
not all of the surgeons in our group were comfortable
with the procedure. The other two patients were excluded
due to their dire clinical situation. One had septic shock
from an infected aneurysm, and the other had hemorrhagic
shock from a bleeding aneurysm. We do not have any ab-
solute contraindication criteria besides the patient being
critically ill.
A relative contraindication may be if there is limited
soft tissue coverage to mobilize ﬂaps, such as in a patient
with a large forearm aneurysm and thin, fragile skin. We
think that it is crucial to protect the remodeled vein under-
neath a healthy tissue ﬂap to prevent recurrent skin erosion.
Because the surgery requires a long incision and extensive
mobilization, we were concerned about tissue ﬂap necrosis,
particularly in patients with prior vein transpositions. No
tissue viability problems occurred in the eight patients
with transposed basilic veins, four patients with superﬁcial-
ized cephalic veins, and 12 patients with forearm AVF an-
eurysms. We did not routinely use intravenous heparin,
which may have contributed to our lack of wound
hematomas.
Our technical success rate of 95% showed that staple
aneurysmorrhaphy was successful in repairing the most
complicated AVF aneurysms. There were two technical fail-
ures. The ﬁrst occurred in one of our ﬁrst few cases and was
caused by disruption of the staple line that resulted in a
pseudoaneurysm. During surgery, it was noted that the
aneurysm wall was very soft and friable. After the stapler
was ﬁred and the redundant wall was resected, there were
multiple bleeding sites that had to be reinforced. A thick
ﬁbrotic aneurysm wall is important for the integrity of
the remodeled vein. The staple line was always hemostatic
when the wall was thick and ﬁbrotic. The second failure
was caused by diffuse and severe calciﬁcation of the vein
that prevented stapling and sewing. Aneurysmorrhaphy
was abandoned and an interposition polytetraﬂuoroethy-
lene graft placed. We caution against performing aneurys-
morrhaphy when the vein wall is friable or severely
calciﬁed.
Most surgeries early in our study period were per-
formed under general anesthesia. As our experience grew,
there was a trend toward using local-regional anesthesia.
We found that local-regional anesthesia was fairly well
tolerated in 70% of the patients, and none required conver-
sion to general anesthesia. The mean operative time for
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Volume 61, Number 2 Vo et al 461general anesthesia was slightly longer than local-regional
anesthesia but did not reach statistical signiﬁcance.
Elevated venous pressure secondary to outﬂow vein ste-
nosis, combined with repeated wall trauma from same site
cannulations, have been cited as contributing to AVF aneu-
rysm formation.13 Most of the outﬂow vein stenoses identi-
ﬁed in our series occurred at the cephalic arch, whichmirrors
other published reports.16,17 These stenotic lesions were
readily detected using ultrasound imaging and physical
ﬁnding of pulsatility. All of the venous stenoses detected
postoperatively were recurrent in nature, except for one.
Most of these were recurrent stenoses at the cephalic arch.
We did not perform routine preoperative venograms. It
may be argued that ultrasound imaging and physical exam-
ination are inadequate and that we may have missed detect-
ing central venous stenoses. Despite our low aneurysm
recurrence rate of 2% with this protocol, we agree that per-
forming routine central venograms of all patients before sur-
gery to detect central venous stenoses is reasonable.
Our primary patency rate was lower than that expected
for a primary AVF. The lower primary patency rate can be
explained by our surveillance policy. Ultrasound imaging
and physical examination were done at 1, 6, and 12 months
and then yearly after repair. Any AVF with ultrasound-
detected stenosis >50% or ﬁnding of pulsatility underwent
venogram, irrespective of any clinical problems. All of the in-
terventions accounting for assisted primary patency were
balloon angioplasty done for detected venous stenoses.
Some have suggested that high ﬂow volumes can
contribute to AVF aneurysmal degeneration.4,13 The mean
ﬂow volume in our cohort was 1711.76 (SD, 758.11) mL/
min. Ten patients had mean ﬂow volume >2 L/min, and
one had ﬂow volume >3 L/min. We did not attempt any
simultaneous inﬂow restriction procedures for fear of causing
thrombosis of the remodeledAVF.Aneurysm recurrencewas
not correlated with high-ﬂow AVFs in our series. However,
adding an inﬂow reduction to AVFs with high ﬂow volumes
and cephalic arch stenoses may have merit, given the high
recurrent stenosis rate at this site.13 The ambiguity lies in
deciding what ﬂow threshold on which to intervene.
Several technical aspects of staple aneurysmorrhaphy
deserve mentioning. First, using the stapler allows the
aneurysm to be remodeled expeditiously. The stapler can
be easily readjusted until the desired diameter is obtained.
The AVF does not need to be opened and a rubber cath-
eter inserted.15 Second, the inﬂow is only arrested for a
few minutes, which obviated the need for systemic heparin.
This may facilitate hemostasis and reduce postoperative
bleeding complications. Third, we routinely added a
running suture to reinforce the staple line. This step is
probably unnecessary because the staple line had adequate
hemostasis most of the time, especially when using an
Endo GIA stapler with a vascular load.
Staple aneurysmorrhaphy was successfully performed in
most patients under local-regional anesthesia and as an
outpatient procedure, despite the extensive dissection and
operative times involved. In another reported series of 14
patients with staple aneurysmorrhaphy, 10 procedureswere done under local-regional anesthesia.11 We prefer us-
ing local-regional anesthesia in chronically ill dialysis pa-
tients when possible, but the decision ultimately rests on
the anesthetic team’s ability to provide regional blocks.
Lastly, we believe that a key aspect is to reposition the
remodeled vein underneath a healthy subcutaneous skin
ﬂap, with the staple line rotated laterally. This prevents
puncturing the staple line and further skin erosion.
One disadvantage of staple aneurysmorrhaphy was that
most of our patients required a temporary hemodialysis cath-
eter that was removed 5 to 6 weeks postoperatively. Many
patients had multiple aneurysms extending the length of their
AVF. This necessitated a long single incision that did not
leave any available sites for needle puncture until the skin
healed. Only three patients in our series had focal aneurysms
that allowed repair and immediate use of the AVF afterwards.
An alternate approach described that allows immediate use of
the AVF is to perform a partial aneurysmectomy. This would
leave available areas for puncture.18 However, recurrence
may be a problem with partial aneurysmectomy because
the aneurysm is not remodeled to normal caliber.
Staging individual aneurysm repairs for AVFs with mul-
tiple aneurysms could have been possible. This would have
left available vein for needle access in the interim, thus
avoiding a hemodialysis catheter. We chose not to do this
because it meant more burdens for the patients in way of
additional visits and multiple surgeries. Of note, the
AVFs in a smaller series of 14 patients were allowed to
be used #24 hours after staple aneurysmorrhaphy.11 We
have not attempted cannulation this early but may consider
curtailing our rest period to a couple of weeks.
CONCLUSIONS
Staple aneurysmorrhaphy is a safe and durable tech-
nique to repair an AVF with aneurysm-related complica-
tions and extend the lifespan of the AVF. Key principles
are to remodel the vein to normal adjacent diameter, pro-
vide healthy skin coverage, and aggressively seek out
concomitant proximal venous stenoses. Whether inﬂow
reduction is required in high-ﬂow AVFs is debatable. The
remodeled AVF has low aneurysm recurrence and main-
tains the beneﬁcial properties of superior patency and low
infection. It is important to aggressively monitor for and
treat outﬂow vein stenoses to prevent recurrence. The sur-
gery can be done with low risks and under local anesthesia
in an outpatient setting in selected patients.
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